Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8511 |
High Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.8413 |
Intermediate Similarity |
NPD1038 |
Approved |
0.8267 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.8265 |
Intermediate Similarity |
NPD4795 |
Phase 2 |
0.8247 |
Intermediate Similarity |
NPD1740 |
Approved |
0.8247 |
Intermediate Similarity |
NPD1739 |
Approved |
0.8216 |
Intermediate Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.8196 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.8109 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.8109 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.809 |
Intermediate Similarity |
NPD1392 |
Approved |
0.801 |
Intermediate Similarity |
NPD4548 |
Discontinued |
0.7982 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.796 |
Intermediate Similarity |
NPD5658 |
Approved |
0.7949 |
Intermediate Similarity |
NPD3477 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD3478 |
Clinical (unspecified phase) |
0.7936 |
Intermediate Similarity |
NPD4440 |
Clinical (unspecified phase) |
0.7923 |
Intermediate Similarity |
NPD3402 |
Phase 1 |
0.7919 |
Intermediate Similarity |
NPD5482 |
Discontinued |
0.7887 |
Intermediate Similarity |
NPD4372 |
Phase 1 |
0.7877 |
Intermediate Similarity |
NPD5559 |
Phase 2 |
0.7871 |
Intermediate Similarity |
NPD2187 |
Approved |
0.7871 |
Intermediate Similarity |
NPD2189 |
Approved |
0.7865 |
Intermediate Similarity |
NPD1034 |
Phase 3 |
0.7865 |
Intermediate Similarity |
NPD1033 |
Clinical (unspecified phase) |
0.7864 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD3003 |
Approved |
0.7838 |
Intermediate Similarity |
NPD565 |
Phase 2 |
0.7828 |
Intermediate Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.7814 |
Intermediate Similarity |
NPD7558 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD3324 |
Clinical (unspecified phase) |
0.7802 |
Intermediate Similarity |
NPD112 |
Approved |
0.7802 |
Intermediate Similarity |
NPD9705 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7739 |
Intermediate Similarity |
NPD1768 |
Approved |
0.7729 |
Intermediate Similarity |
NPD6140 |
Clinical (unspecified phase) |
0.7725 |
Intermediate Similarity |
NPD1856 |
Discontinued |
0.772 |
Intermediate Similarity |
NPD5256 |
Discontinued |
0.7704 |
Intermediate Similarity |
NPD6569 |
Phase 2 |
0.7703 |
Intermediate Similarity |
NPD4429 |
Discontinued |
0.7678 |
Intermediate Similarity |
NPD4881 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD3939 |
Suspended |
0.7665 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD5903 |
Approved |
0.7644 |
Intermediate Similarity |
NPD5902 |
Approved |
0.7633 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.763 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.7626 |
Intermediate Similarity |
NPD4958 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7617 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7613 |
Intermediate Similarity |
NPD7067 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7068 |
Approved |
0.7596 |
Intermediate Similarity |
NPD2581 |
Approved |
0.7596 |
Intermediate Similarity |
NPD2582 |
Approved |
0.7596 |
Intermediate Similarity |
NPD1322 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD6872 |
Clinical (unspecified phase) |
0.7583 |
Intermediate Similarity |
NPD7194 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7549 |
Intermediate Similarity |
NPD4035 |
Approved |
0.7549 |
Intermediate Similarity |
NPD4038 |
Approved |
0.7549 |
Intermediate Similarity |
NPD4037 |
Approved |
0.7549 |
Intermediate Similarity |
NPD4033 |
Approved |
0.7549 |
Intermediate Similarity |
NPD32 |
Approved |
0.7549 |
Intermediate Similarity |
NPD4034 |
Approved |
0.7549 |
Intermediate Similarity |
NPD4039 |
Approved |
0.7549 |
Intermediate Similarity |
NPD31 |
Approved |
0.7549 |
Intermediate Similarity |
NPD4036 |
Approved |
0.7549 |
Intermediate Similarity |
NPD4122 |
Approved |
0.7538 |
Intermediate Similarity |
NPD4919 |
Phase 3 |
0.7538 |
Intermediate Similarity |
NPD4920 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD4921 |
Phase 3 |
0.7535 |
Intermediate Similarity |
NPD1273 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD1418 |
Phase 2 |
0.7513 |
Intermediate Similarity |
NPD4204 |
Approved |
0.7513 |
Intermediate Similarity |
NPD1078 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD4203 |
Approved |
0.7512 |
Intermediate Similarity |
NPD8512 |
Phase 3 |
0.7511 |
Intermediate Similarity |
NPD3343 |
Phase 3 |
0.7511 |
Intermediate Similarity |
NPD5450 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4131 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD3006 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1259 |
Discontinued |
0.7488 |
Intermediate Similarity |
NPD1258 |
Discontinued |
0.7475 |
Intermediate Similarity |
NPD5999 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD6202 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD425 |
Approved |
0.7447 |
Intermediate Similarity |
NPD424 |
Approved |
0.7441 |
Intermediate Similarity |
NPD6643 |
Discontinued |
0.7437 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7437 |
Intermediate Similarity |
NPD3924 |
Approved |
0.7437 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7437 |
Intermediate Similarity |
NPD3921 |
Approved |
0.7431 |
Intermediate Similarity |
NPD6968 |
Phase 2 |
0.7431 |
Intermediate Similarity |
NPD6969 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD8403 |
Phase 1 |
0.7423 |
Intermediate Similarity |
NPD7414 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD949 |
Phase 1 |
0.7409 |
Intermediate Similarity |
NPD2472 |
Approved |
0.7409 |
Intermediate Similarity |
NPD2471 |
Approved |
0.7404 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.7398 |
Intermediate Similarity |
NPD4889 |
Approved |
0.7391 |
Intermediate Similarity |
NPD7222 |
Phase 2 |
0.7387 |
Intermediate Similarity |
NPD5913 |
Phase 3 |
0.7387 |
Intermediate Similarity |
NPD5912 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD6769 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD6985 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD5632 |
Approved |
0.7363 |
Intermediate Similarity |
NPD6861 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD706 |
Phase 1 |
0.7359 |
Intermediate Similarity |
NPD6961 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD4072 |
Approved |
0.7358 |
Intermediate Similarity |
NPD4071 |
Approved |
0.7358 |
Intermediate Similarity |
NPD1032 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD484 |
Approved |
0.7352 |
Intermediate Similarity |
NPD5022 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD5083 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD9690 |
Approved |
0.7343 |
Intermediate Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD4454 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3386 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4502 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD3570 |
Phase 2 |
0.7322 |
Intermediate Similarity |
NPD5018 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD1620 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD9574 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7424 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD3815 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD3816 |
Phase 1 |
0.7295 |
Intermediate Similarity |
NPD3397 |
Phase 2 |
0.7291 |
Intermediate Similarity |
NPD2952 |
Discontinued |
0.7281 |
Intermediate Similarity |
NPD6306 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD3395 |
Approved |
0.7277 |
Intermediate Similarity |
NPD3396 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5863 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5529 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD604 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5528 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2509 |
Approved |
0.726 |
Intermediate Similarity |
NPD5530 |
Phase 1 |
0.7257 |
Intermediate Similarity |
NPD6473 |
Phase 1 |
0.7256 |
Intermediate Similarity |
NPD3514 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD4558 |
Phase 2 |
0.7249 |
Intermediate Similarity |
NPD5644 |
Phase 1 |
0.7248 |
Intermediate Similarity |
NPD2954 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2955 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4890 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8442 |
Discontinued |
0.724 |
Intermediate Similarity |
NPD6131 |
Phase 1 |
0.724 |
Intermediate Similarity |
NPD2062 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD4344 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD4343 |
Phase 1 |
0.7225 |
Intermediate Similarity |
NPD7453 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7452 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1722 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5930 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD7051 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD7050 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD2334 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD5948 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6750 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD5669 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD4418 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD6590 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD9706 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD1910 |
Approved |
0.7182 |
Intermediate Similarity |
NPD6553 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD1911 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6159 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD5601 |
Phase 2 |
0.7177 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD6223 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD6494 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD6220 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD3938 |
Phase 1 |
0.7163 |
Intermediate Similarity |
NPD3440 |
Clinical (unspecified phase) |
0.7156 |
Intermediate Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.715 |
Intermediate Similarity |
NPD6257 |
Clinical (unspecified phase) |
0.7149 |
Intermediate Similarity |
NPD5802 |
Phase 2 |
0.7149 |
Intermediate Similarity |
NPD1941 |
Approved |
0.7136 |
Intermediate Similarity |
NPD7676 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD4927 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD7675 |
Phase 3 |
0.7136 |
Intermediate Similarity |
NPD7426 |
Phase 1 |
0.7136 |
Intermediate Similarity |
NPD7674 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD5069 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD198 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD3833 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD3835 |
Phase 3 |
0.7129 |
Intermediate Similarity |
NPD4148 |
Approved |
0.7129 |
Intermediate Similarity |
NPD1286 |
Suspended |
0.7122 |
Intermediate Similarity |
NPD1622 |
Discontinued |
0.7122 |
Intermediate Similarity |
NPD1229 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD2782 |
Approved |
0.712 |
Intermediate Similarity |
NPD2780 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5479 |
Discontinued |
0.7116
|
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |